Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2005, Bridge Investment Fund L.P. is a venture capital firm based in Cleveland, Ohio. The firm specializes in early-to-mid stage investments in Israeli medical device companies, particularly those that have completed initial clinical trials. With a fund size of approximately $8 million, Bridge Investment Fund aims to facilitate the entry of these companies into the US market by leveraging the resources and expertise of Cleveland's renowned healthcare institutions, including the Cleveland Clinic and Case Western Reserve University.
Bridge Investment Fund operates from offices in both Cleveland and Tel Aviv, allowing it to maintain strong connections with the Israeli tech ecosystem while also tapping into the rich healthcare landscape of Cleveland. The firm has established itself as a key player in transferring Israeli medical device innovations to the US market, focusing on companies that are ready for clinical validation and commercialization.
Bridge Investment Fund specializes in investing in Israeli medical device companies that have synergies with Cleveland's healthcare ecosystem. The firm targets companies that have completed initial clinical trials and are poised for US clinical validation and commercial entry. Investment stages include seed and Series A, with check sizes ranging from $250,000 to $1 million.
The fund's geographic focus spans North America and Asia, emphasizing the importance of connecting Israeli innovations with US healthcare resources. Bridge Investment Fund seeks to support companies that can leverage Cleveland's healthcare institutions for validation and commercialization, thereby enhancing their growth potential in the competitive medical device market.
Bridge Investment Fund has a notable portfolio that includes:
These companies exemplify the fund's focus on innovative medical technologies that align with the needs of the US healthcare market.
Michael Goldberg - Co-founder of Bridge Investment Fund, Michael Goldberg has a background in venture capital and is currently a faculty member at Case Western Reserve University, where he is involved with the ISSACS Institute. He is deeply embedded in the Cleveland-Israel tech bridge ecosystem and has played a significant role in the fund's strategy and operations.
Avshalom Horan - Co-founder responsible for Israel-side operations, Avshalom Horan brings expertise in managing investments and fostering relationships with Israeli medical device companies. His role is crucial in identifying promising startups that align with the fund's investment focus.
To pitch Bridge Investment Fund, founders should reach out through a warm introduction, ideally from someone within the healthcare or investment community. A well-prepared pitch deck should include details on the technology, market opportunity, and clinical validation status. Response times can vary, but founders should expect a thorough review process given the fund's focus on strategic alignment with its investment thesis.
In 2011, Bridge Investment Fund celebrated the IPO of its portfolio company, IceCure, which raised $10 million. This event marked a significant milestone for the fund, showcasing its ability to support companies in achieving successful exits.
Additionally, Navotek received FDA clearance for its radiation therapy monitoring system around the same time, further highlighting the fund's commitment to facilitating clinical validation for its portfolio companies.
What are Bridge Investment Fund's investment criteria?
Bridge Investment Fund focuses on early-to-mid stage Israeli medical device companies that have completed initial clinical trials. The firm looks for companies that are ready for US clinical validation and commercialization, particularly those with synergies to Cleveland's healthcare ecosystem.
How can I pitch to Bridge Investment Fund?
Founders should prepare a detailed pitch deck that outlines their technology, market potential, and clinical validation status. A warm introduction through mutual connections in the healthcare or investment sectors can enhance the chances of securing a meeting.
What makes Bridge Investment Fund different from other VCs?
Bridge Investment Fund uniquely leverages its deep connections within Cleveland's healthcare institutions, providing portfolio companies with access to clinical validation, commercialization support, and strategic partnerships that are critical for success in the US market.
What is the typical check size for investments?
The firm typically invests between $250,000 and $1 million per company, depending on the specific needs and growth stage of the startup.
What is the geographic focus of Bridge Investment Fund?
Bridge Investment Fund primarily focuses on North America and Asia, specifically targeting Israeli medical device companies that can benefit from the resources available in Cleveland's healthcare ecosystem.
What kind of post-investment support does Bridge Investment Fund provide?
The fund adds value by facilitating connections with leading medical institutions, offering guidance on clinical validation processes, and assisting with commercialization strategies to help portfolio companies succeed in the US market.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.